Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.
With visual needs rising substantially in recent years, eye conditions such as cataract have been shown to be more impactful at an earlier age, said Raj Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision.
Transcript
Can you speak on the growing prevalence of cataracts in younger populations?
I wouldn't say that they're necessarily being noticed at an earlier age, I think it's just more impactful at an earlier age because of our visual needs. So, certainly all of the types of conditions we've talked about that can contribute to cataracts at an earlier age, we still need to watch for.
Again, whether they're medical causes, trauma, or medications as examples, but because of our greater visual needs, we are finding that we're doing cataract surgery at an earlier age because patients’ vision is impacting their life and that's when we primarily choose to perform cataract surgery.
It’s when a patient's vision is impacting their daily functioning, and therefore then we can, by cataract surgery, remove the natural lens, the cloudy lens of the eye, and implant an intraocular lens that makes up for the power. And then we have different options in how we select those intraocular lenses and what we do in cataract surgery.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More